Recombinant human superoxide dismutase

Recombinant human superoxide dismutase
Trade Name Oxsodrol
Orphan Indication Bronchopulmonary dysplasia
USA Market Approval USA
USA Designation Date 1991-04-18 00:00:00
Sponsor Savient Pharmaceuticals, Inc.;One Tower Center Boulevard, 12th floor;East Brunswick, New Jersey, 08816